{"entity":{"id":"nct04104776","kind":"trial","name":"A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas","aka":[],"tldr":"A phase 1/2 trial of Enzalutamide in diffuse large b-cell lymphoma and mesothelioma, run by Novartis Pharmaceuticals, now recruiting.","summary":"A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas is a phase 1/2 interventional study registered as NCT04104776 by Novartis Pharmaceuticals, with 300 participants planned, started 2019-09-18 and due to reach its primary completion in 2030-02-27. Interventions recorded: Tulmimetostat, Enzalutamide. Conditions listed: Advanced Solid Tumor, Diffuse Large B Cell Lymphoma, Lymphoma, T-Cell, Mesothelioma, Malignant. No results are recorded here; the registry entry is the source.","status":"recruiting","asOf":"2026-09-16","links":[{"label":"ClinicalTrials.gov NCT04104776","url":"https://clinicaltrials.gov/study/NCT04104776"}],"tags":["ctgov-ingest"],"related":[],"cancers":["dlbcl","mesothelioma","endometrial","prostate"],"sections":[],"technologies":[],"targets":[],"drugs":["enzalutamide"],"companies":["novartis"],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"notes":[],"nct":"NCT04104776","phase":"1/2","setting":"A Phase 1/2 Study of DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas","sponsor":"Novartis Pharmaceuticals","enrolled":300,"outcomes":[]},"route":"/trials/nct04104776/","neighbours":{"cancer":[{"id":"dlbcl","kind":"cancer","name":"Diffuse large B-cell lymphoma","route":"/cancers/dlbcl/"},{"id":"endometrial","kind":"cancer","name":"Endometrial cancer","route":"/cancers/endometrial/"},{"id":"mesothelioma","kind":"cancer","name":"Mesothelioma","route":"/cancers/mesothelioma/"},{"id":"prostate","kind":"cancer","name":"Prostate cancer","route":"/cancers/prostate/"}],"drug":[{"id":"enzalutamide","kind":"drug","name":"Enzalutamide","route":"/drugs/enzalutamide/"}],"company":[{"id":"novartis","kind":"company","name":"Novartis","route":"/companies/novartis/"}]}}